WKYMVm Works by Targeting Immune Cells

References

• Ye RD, Boulay F, Wang JM, et al. International union of basic and clinical pharmacology. LXXIII. nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev. 2009;61(2):119–161. doi:10.1124/pr.109.001578
   PubMed Web of Science ®Google Scholar
• Gao JL, Chen H, Filie JD, Kozak CA, Murphy PM. Differential expansion of the N-formylpeptide receptor gene cluster in human and mouse. Genomics. 1998;51(2):270–276. doi:10.1006/geno.1998.5376
   Web of Science ®Google Scholar
• Rotrosen D, Malech HL, Gallin JI. Formyl peptide leukocyte chemoattractant uptake and release by cultured human umbilical vein endothelial cells. J Immunol. 1987;139(9):3034–3040.
   Web of Science ®Google Scholar
• Lacy M, Jones J, Whittemore SR, Haviland DL, Wetsel RA, Barnum SR. Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia. J Neuroimmunol. 1995;61(1):71–78. doi:10.1016/0165-5728(95)00075-d
   PubMed Web of Science ®Google Scholar
• McCoy R, Haviland DL, Molmenti EP, Ziambaras T, Wetsel RA, Perlmutter DH. N-formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation. J Exp Med. 1995;182(1):207–217. doi:10.1084/jem.182.1.207
   PubMed Web of Science ®Google Scholar
• Hou XL, Ji CD, Tang J, et al. FPR2 promotes invasion and metastasis of gastric cancer cells and predicts the prognosis of patients. Sci Rep. 2017;7(1):3153. doi:10.1038/s41598-017-03368-7
   Google Scholar
• Crocetti L, Vergelli C, Guerrini G, et al. Novel formyl peptide receptor (FPR) agonists with pyridinone and pyrimidindione scaffolds that are potentially useful for the treatment of rheumatoid arthritis. Bioorg Chem. 2020;100:103880. doi:10.1016/j.bioorg.2020.103880
   Web of Science ®Google Scholar
• Kim SD, Kim JM, Jo SH, et al. Functional expression of formyl peptide receptor family in human NK cells. J Immunol. 2009;183(9):5511–5517. doi:10.4049/jimmunol.0802986
   Web of Science ®Google Scholar
• Yang D, Chen Q, Le Y, Wang JM, Oppenheim JJ. Differential regulation of formyl peptide receptor-like 1 expression during the differentiation of monocytes to dendritic cells and macrophages. J Immunol. 2001;166(6):4092–4098. doi:10.4049/jimmunol.166.6.4092
   PubMed Web of Science ®Google Scholar
• Yang D, Chen Q, Gertz B, et al. Human dendritic cells express functional formyl peptide receptor-like-2 (FPRL2) throughout maturation. J Leukoc Biol. 2002;72(3):598–607. doi:10.1189/jlb.72.3.598
   PubMed Web of Science ®Google Scholar
• Migeotte I, Riboldi E, Franssen JD, et al. Identification and characterization of an endogenous chemotactic ligand specific for FPRL2. J Exp Med. 2005;201(1):83–93. doi:10.1084/jem.20041277
   Web of Science ®Google Scholar
• Rabiet MJ, Huet E, Boulay F. Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR. Eur J Immunol. 2005;35(8):2486–2495. doi:10.1002/eji.200526338
   PubMed Web of Science ®Google Scholar
• Baek SH, Seo JK, Chae CB, Suh PG, Ryu SH. Identification of the peptides that stimulate the phosphoinositide hydrolysis in lymphocyte cell lines from peptide libraries. J Biol Chem. 1996;271(14):8170–8175. doi:10.1074/jbc.271.14.8170
   Web of Science ®Google Scholar
• Le Y, Gong W, Li B, et al. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation. J Immunol. 1999;163(12):6777–6784.
   Web of Science ®Google Scholar
• Christophe T, Karlsson A, Dugave C, Rabiet MJ, Boulay F, Dahlgren C. The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2. J Biol Chem. 2001;276(24):21585–21593. doi:10.1074/jbc.M007769200
   Web of Science ®Google Scholar
• Kim SD, Kim YK, Lee HY, et al. The agonists of formyl peptide receptors prevent development of severe sepsis after microbial infection. J Immunol. 2010;185(7):4302–4310. doi:10.4049/jimmunol.1001310
   Web of Science ®Google Scholar
• Horewicz VV, Crestani S, de Sordi R, Rezende E, Assreuy J. FPR2/ALX activation reverses LPS-induced vascular hyporeactivity in aorta and increases survival in a pneumosepsis model. Eur J Pharmacol. 2015;746:267–273. doi:10.1016/j.ejphar.2014.11.026
   Web of Science ®Google Scholar
• Kim YE, Park WS, Ahn SY, et al. WKYMVm hexapeptide, a strong formyl peptide receptor 2 agonist, attenuates hyperoxia-induced lung injuries in newborn mice. Sci Rep. 2019;9(1):6815. doi:10.1038/s41598-019-43321-4
   Google Scholar
• Lee H, Lee J, Park Y, Kim JH, Eickelberg O, Yang SR. WKYMVm ameliorates acute lung injury via neutrophil antimicrobial peptide derived STAT1/IRF1 pathway. Biochem Biophys Res Commun. 2020;533(3):313–318. doi:10.1016/j.bbrc.2020.09.036
   Web of Science ®Google Scholar
• Kim H, Park JH, Lee EH, et al. Granulocyte function is stimulated by a novel hexapeptide, WKYMVm, in chemotherapy-treated cancer patients. Exp Hematol. 2006;34(4):407–413. doi:10.1016/j.exphem.2006.01.010
   Web of Science ®Google Scholar
• Kim SD, Lee HY, Shim JW, et al. A WKYMVm-containing combination elicits potent anti-tumor activity in heterotopic cancer animal model. PLoS One. 2012;7(1):e30522. doi:10.1371/journal.pone.0030522
   Web of Science ®Google Scholar
• Hu J, Li X, Chen Y, et al. The protective effect of WKYMVm peptide on inflammatory osteolysis through regulating NF-κB and CD9/gp130/STAT3 signalling pathway. J Cell Mol Med. 2020;24(2):1893–1905. doi:10.1111/jcmm.14885
   Web of Science ®Google Scholar
• Yoon JH, Kim D, Jang JH, et al. Proteomic analysis of the palmitate-induced myotube secretome reveals involvement of the annexin A1-formyl peptide receptor 2 (FPR2) pathway in insulin resistance. Mol Cell Proteomics. 2015;14(4):882–892. doi:10.1074/mcp.M114.039651
   PubMed Web of Science ®Google Scholar
• Kwon YW, Bae S, Jo YS, Seo Y, Yoon JH. Stimulation of the migration and expansion of adult mouse neural stem cells by the FPR2-specific peptide WKYMVm. Life. 2021;11:11. doi:10.3390/life11111248
   Google Scholar
• Jun JH, Park SY, Park S, et al. Formyl peptide receptor 2 alleviates hepatic fibrosis in liver cirrhosis by vascular remodeling. Int J Mol Sci. 2021;22(4):2107. doi:10.3390/ijms22042107
   Web of Science ®Google Scholar
• Cattaneo F, Iaccio A, Guerra G, Montagnani S, Ammendola R. NADPH-oxidase-dependent reactive oxygen species mediate EGFR transactivation by FPRL1 in WKYMVm-stimulated human lung cancer cells. Free Radic Biol Med. 2011;51(6):1126–1136. doi:10.1016/j.freeradbiomed.2011.05.040
   Web of Science ®Google Scholar
• Zhang W, Chen J, Guo W, et al. WKYMVm/FPR2 alleviates spinal cord injury by attenuating the inflammatory response of microglia. Mediators Inflamm. 2022;2022:4408099. doi:10.1155/2022/4408099
   Web of Science ®Google Scholar
• Sato AK, Viswanathan M, Kent RB, Wood CR. Therapeutic peptides: technological advances driving peptides into development. Curr Opin Biotechnol. 2006;17(6):638–642. doi:10.1016/j.copbio.2006.10.002
   PubMed Web of Science ®Google Scholar
• Lee BI, Park MH, Heo SC, et al. Quantification and application of a liquid chromatography-tandem mass spectrometric method for the determination of WKYMVm peptide in rat using solid-phase extraction. Biomed Chromatogr. 2018;32(3):5. doi:10.1002/bmc.4107
   Web of Science ®Google Scholar
• Park S, Kim SD, Lee HY, et al. A novel delivery platform for therapeutic peptides. Biochem Biophys Res Commun. 2014;450(1):13–18. doi:10.1016/j.bbrc.2014.05.049
   Web of Science ®Google Scholar
• Choi YH, Heo SC, Kwon YW, et al. Injectable PLGA microspheres encapsulating WKYMVM peptide for neovascularization. Acta Biomater. 2015;25:76–85. doi:10.1016/j.actbio.2015.07.033
   PubMed Web of Science ®Google Scholar
• Bae YS, Kim Y, Kim Y, Kim JH, Suh PG, Ryu SH. Trp-Lys-Tyr-Met-Val-D-Met is a chemoattractant for human phagocytic cells. J Leukoc Biol. 1999;66(6):915–922. doi:10.1002/jlb.66.6.915
   Web of Science ®Google Scholar
• O’Flaherty JT, Jacobson DP, Redman JF, Rossi AG. Translocation of protein kinase C in human polymorphonuclear neutrophils. Regulation by cytosolic Ca2(+)-independent and Ca2(+)-dependent mechanisms. J Biol Chem. 1990;265(16):9146–9152. doi:10.1016/S0021-9258(19)38823-4
   Web of Science ®Google Scholar
• Dorward DA, Lucas CD, Chapman GB, Haslett C, Dhaliwal K, Rossi AG. The role of formylated peptides and formyl peptide receptor 1 in governing neutrophil function during acute inflammation. Am J Pathol. 2015;185(5):1172–1184. doi:10.1016/j.ajpath.2015.01.020
   PubMed Web of Science ®Google Scholar
• Hao L, Lei X, Zhou H, Marshall AJ, Liu L. Critical role for PI3Kγ-dependent neutrophil reactive oxygen species in WKYMVm-induced microvascular hyperpermeability. J Leukoc Biol. 2019;106(5):1117–1127. doi:10.1002/jlb.3a0518-184rr
   Web of Science ®Google Scholar
• Kang HK, Lee HY, Kim MK, et al. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met inhibits human monocyte-derived dendritic cell maturation via formyl peptide receptor and formyl peptide receptor-like 2. J Immunol. 2005;175(2):685–692. doi:10.4049/jimmunol.175.2.685
   Web of Science ®Google Scholar
• Kumar V, Sharma A. Neutrophils: Cinderella of innate immune system. Int Immunopharmacol. 2010;10(11):1325–1334. doi:10.1016/j.intimp.2010.08.012
   PubMed Web of Science ®Google Scholar
• Filippi MD. Neutrophil transendothelial migration: updates and new perspectives. Blood. 2019;133(20):2149–2158. doi:10.1182/blood-2018-12-844605
   PubMed Web of Science ®Google Scholar
• Vorobjeva NV, Chernyak BV. NETosis: molecular mechanisms, role in physiology and pathology. Biochemistry. 2020;85(10):1178–1190. doi:10.1134/s0006297920100065
   Web of Science ®Google Scholar
• Karlsson J, Fu H, Boulay F, Bylund J, Dahlgren C. The peptide Trp-Lys-Tyr-Met-Val-D-Met activates neutrophils through the formyl peptide receptor only when signaling through the formylpeptide receptor like 1 is blocked. A receptor switch with implications for signal transduction studies with inhibitors and receptor antagonists. Biochem Pharmacol. 2006;71(10):1488–1496. doi:10.1016/j.bcp.2006.02.010
   Web of Science ®Google Scholar
• Kim HS, Park MY, Lee SK, Park JS, Lee HY, Bae YS. Activation of formyl peptide receptor 2 by WKYMVm enhances emergency granulopoiesis through phospholipase C activity. BMB Rep. 2018;51(8):418–423. doi:10.5483/BMBRep.2018.51.8.080
   Web of Science ®Google Scholar
• Björkman L, Forsman H, Önnheim K. Data on the NADPH-oxidase activity induced by WKYMVm and galectin-3 in bone marrow derived and exudated neutrophils isolated from four different mouse strains. Data Brief. 2017;10:349–353. doi:10.1016/j.dib.2016.12.010
   Google Scholar
• Onnheim K, Bylund J, Boulay F, Dahlgren C, Forsman H. Tumour necrosis factor (TNF)-alpha primes murine neutrophils when triggered via formyl peptide receptor-related sequence 2, the murine orthologue of human formyl peptide receptor-like 1, through a process involving the type I TNF receptor and subcellular granule mobilization. Immunology. 2008;125(4):591–600. doi:10.1111/j.1365-2567.2008.02873.x
   Web of Science ®Google Scholar
• Kim H, Noh EK, Lee EJ, et al. Enhanced bactericidal function by WKYMVm in patients with acute leukemia. Leuk Res. 2008;32(5):717–725. doi:10.1016/j.leukres.2007.09.006
   Web of Science ®Google Scholar
• Boxio R, Bossenmeyer-Pourié C, Vanderesse R, Dournon C, Nüsse O. The immunostimulatory peptide WKYMVm-NH activates bone marrow mouse neutrophils via multiple signal transduction pathways. Scand J Immunol. 2005;62(2):140–147. doi:10.1111/j.1365-3083.2005.01651.x
   Web of Science ®Google Scholar
• Lee HY, Jo SH, Lee C, Baek S-H, Bae Y-S. Differential production of leukotriene B4 or prostaglandin E2 by WKYMVm or serum amyloid A via formyl peptide receptor-like 1. Biochem Pharmacol. 2006;72(7):860–868. doi:10.1016/j.bcp.2006.06.022
   Web of Science ®Google Scholar
• Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 2001;294(5548):1871–1875. doi:10.1126/science.294.5548.1871
   PubMed Web of Science ®Google Scholar
• van Furth R, Cohn ZA. The origin and kinetics of mononuclear phagocytes. J Exp Med. 1968;128(3):415–435. doi:10.1084/jem.128.3.415
   PubMed Web of Science ®Google Scholar
• Serbina NV, Jia T, Hohl TM, Pamer EG. Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol. 2008;26:421–452. doi:10.1146/annurev.immunol.26.021607.090326
   PubMed Web of Science ®Google Scholar
• Bae YS, Ju SA, Kim JY, et al. Trp-Lys-Tyr-Met-Val-D-Met stimulates superoxide generation and killing of Staphylococcus aureus via phospholipase D activation in human monocytes. J Leukoc Biol. 1999;65(2):241–248. doi:10.1002/jlb.65.2.241
   PubMed Web of Science ®Google Scholar
• Bae YS, Kim Y, Kim JH, Lee TG, Suh PG, Ryu SH. Independent functioning of cytosolic phospholipase A2 and phospholipase D1 in Trp-Lys-Tyr-Met-Val-D-Met-induced superoxide generation in human monocytes. J Immunol. 2000;164(8):4089–4096. doi:10.4049/jimmunol.164.8.4089
   Web of Science ®Google Scholar
• Stout RD, Suttles J. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol. 2004;76(3):509–513. doi:10.1189/jlb.0504272
   PubMed Web of Science ®Google Scholar
• Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity. 2010;32(5):593–604. doi:10.1016/j.immuni.2010.05.007
   PubMed Web of Science ®Google Scholar
• Izquierdo E, Cuevas VD, Fernández-Arroyo S, et al. Reshaping of human macrophage polarization through modulation of glucose catabolic pathways. J Immunol. 2015;195(5):2442–2451. doi:10.4049/jimmunol.1403045
   Web of Science ®Google Scholar
• Park GT, Kwon YW, Lee TW, et al. Formyl peptide receptor 2 activation ameliorates dermal fibrosis and inflammation in bleomycin-induced scleroderma. Front Immunol. 2019;10:2095. doi:10.3389/fimmu.2019.02095
   PubMed Web of Science ®Google Scholar
• Kwon YW, Heo SC, Jang IH, et al. Stimulation of cutaneous wound healing by an FPR2-specific peptide agonist WKYMVm. Wound Repair Regen. 2015;23(4):575–582. doi:10.1111/wrr.12315
   Web of Science ®Google Scholar
• Han X, Hu J, Zhao W, Lu H, Dai J, He Q. Hexapeptide induces M2 macrophage polarization via the JAK1/STAT6 pathway to promote angiogenesis in bone repair. Exp Cell Res. 2022;413(1):113064. doi:10.1016/j.yexcr.2022.113064
   Web of Science ®Google Scholar
• Zhao W, Hu J, He Q. The effect of the WKYMVm peptide on promoting mBMSC secretion of exosomes to induce M2 macrophage polarization through the FPR2 pathway. J Orthop Surg Res. 2021;16(1):171. doi:10.1186/s13018-021-02321-9
   PubMed Web of Science ®Google Scholar
• Domínguez-Andrés J, Joosten LA, Netea MG. Induction of innate immune memory: the role of cellular metabolism. Curr Opin Immunol. 2019;56:10–16. doi:10.1016/j.coi.2018.09.001
   PubMed Web of Science ®Google Scholar
• Collin M, Bigley V. Human dendritic cell subsets: an update. Immunology. 2018;154(1):3–20. doi:10.1111/imm.12888
   PubMed Web of Science ®Google Scholar
• Gardner A, Ruffell B. Dendritic cells and cancer immunity. Trends Immunol. 2016;37(12):855–865. doi:10.1016/j.it.2016.09.006
   PubMed Web of Science ®Google Scholar
• Tiberio L, Del Prete A, Schioppa T, Sozio F, Bosisio D, Sozzani S. Chemokine and chemotactic signals in dendritic cell migration. Cell Mol Immunol. 2018;15(4):346–352. doi:10.1038/s41423-018-0005-3
   PubMed Web of Science ®Google Scholar
• Lee CG, Choi SY, Park SH, Park KS, Ryu SH, Sung YC. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met as a novel adjuvant for DNA vaccine. Vaccine. 2005;23(38):4703–4710. doi:10.1016/j.vaccine.2005.03.051
   Web of Science ®Google Scholar
• Tae YM, Park HT, Moon HG, et al. Airway activation of formyl peptide receptors inhibits Th1 and Th17 cell responses via inhibition of mediator release from immune and inflammatory cells and maturation of dendritic cells. J Immunol. 2012;188(4):1799–1808. doi:10.4049/jimmunol.1102481
   PubMed Web of Science ®Google Scholar
• Park B, Lee M, Kim SD, et al. Activation of formyl peptide receptor 1 elicits therapeutic effects against collagen-induced arthritis. J Cell Mol Med. 2021;25(18):8936–8946. doi:10.1111/jcmm.16854
   Web of Science ®Google Scholar
• French AR, Yokoyama WM. Natural killer cells and viral infections. Curr Opin Immunol. 2003;15(1):45–51. doi:10.1016/s095279150200002x
   Web of Science ®Google Scholar
• Wu J, Lanier LL. Natural killer cells and cancer. Adv Cancer Res. 2003;90:127–156. doi:10.1016/s0065-230x(03)90004-2
   PubMed Web of Science ®Google Scholar
• Liu J, Li J, Zeng X, et al. Formyl peptide receptor suppresses melanoma development and promotes NK cell migration. Inflammation. 2014;37(3):984–992. doi:10.1007/s10753-014-9819-z
   Web of Science ®Google Scholar